Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cong Luo

Showing results (441-450 of 447) with videos related to

Pageof 45
Sort By:
You have reached the last page of results.This site can display upto 447 results.
Nature Communications|August 27, 2024
RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatmentXinzhu Shan, Zhiqiang Zhao, Pingping Lai, et al.
Nature Materials|June 2, 2026
Magnetoelectric microrobots for spinal cord injury regenerationHao Ye, Jingjing Zang, Jiawei Zhu, et al.
Gut|October 28, 2025
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infectionShichuan Tang, Tingfeng Huang, Ruijing Tang, et al.
JAMA Neurology|August 26, 2024
Endovascular vs Medical Management of Acute Basilar Artery Occlusion: A Secondary Analysis of a Randomized Clinical TrialRui Li, Chunrong Tao, Jun Sun, et al.
Journal of Hepatology|July 6, 2026
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trialQi Xu, Shurui Zhou, Chenbo Zhang, et al.
JAMA Neurology|December 29, 2025
Endovascular vs Medical Treatment of Basilar Artery Occlusion: 3-Year Outcomes of the ATTENTION Randomized Clinical TrialWei Hu, Chunrong Tao, Rui Li, et al.
Nature|April 24, 2025
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injuryWei Ruan, Tao Li, In Hyuk Bang, et al.
Pageof 45

Showing results (441-450 of 447) with videos related to

Sort By:
Pageof 45
You have reached the last page of results.This site can display upto 447 results.
Nature Communications|August 27, 2024
RNA nanotherapeutics with fibrosis overexpression and retention for MASH treatmentXinzhu Shan, Zhiqiang Zhao, Pingping Lai, et al.
Nature Materials|June 2, 2026
Magnetoelectric microrobots for spinal cord injury regenerationHao Ye, Jingjing Zang, Jiawei Zhu, et al.
Gut|October 28, 2025
EASL 2025 indications revisited: phase-specific outcomes with and without nucleos(t)ide analogue therapy in chronic hepatitis B virus infectionShichuan Tang, Tingfeng Huang, Ruijing Tang, et al.
JAMA Neurology|August 26, 2024
Endovascular vs Medical Management of Acute Basilar Artery Occlusion: A Secondary Analysis of a Randomized Clinical TrialRui Li, Chunrong Tao, Jun Sun, et al.
Journal of Hepatology|July 6, 2026
Ivonescimab plus gemcitabine and cisplatin as first-line therapy for advanced biliary tract cancer: a multicenter, open-label phase 2 trialQi Xu, Shurui Zhou, Chenbo Zhang, et al.
JAMA Neurology|December 29, 2025
Endovascular vs Medical Treatment of Basilar Artery Occlusion: 3-Year Outcomes of the ATTENTION Randomized Clinical TrialWei Hu, Chunrong Tao, Rui Li, et al.
Nature|April 24, 2025
BMAL1-HIF2A heterodimer modulates circadian variations of myocardial injuryWei Ruan, Tao Li, In Hyuk Bang, et al.
Pageof 45